ArticleDigestive diseases and sciences2024

Gliclazide Reduces Colitis-Associated Colorectal Cancer Formation by Deceasing Colonic Inflammation and Regulating AMPK-NF-κB Signaling Pathway.

Shuai Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.